Millennium Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-389,020
| Closed | -$373K | – | 6838 |
|
|
2023
Q2 | $373K | Sell |
389,020
-337,139
| -46% | -$333K | ﹤0.01% | 4744 |
|
|
2023
Q1 | $545K | Sell |
726,159
-527,563
| -42% | -$385K | ﹤0.01% | 4551 |
|
|
2022
Q4 | $462K | Sell |
1,253,722
-301,460
| -19% | -$127K | ﹤0.01% | 4800 |
|
|
2022
Q3 | $669K | Sell |
1,555,182
-1,125,918
| -42% | -$1.11M | ﹤0.01% | 4702 |
|
|
2022
Q2 | $2.09M | Buy |
2,681,100
+1,923,371
| +254% | +$1.7M | ﹤0.01% | 3664 |
|
|
2022
Q1 | $977K | Sell |
757,729
-2,226,469
| -75% | -$2.05M | ﹤0.01% | 4546 |
|
|
2021
Q4 | $3.79M | Buy |
2,984,198
+2,906,421
| +3,737% | +$5.2M | ﹤0.01% | 3174 |
|
|
2021
Q3 | $170K | Buy |
77,777
+29,719
| +62% | +$81.2K | ﹤0.01% | 6207 |
|
|
2021
Q2 | $180K | Buy |
+48,058
| New | +$167K | ﹤0.01% | 6060 |
|
|
2020
Q4 | – | Sell |
-517,536
| Closed | -$2.13M | – | 5711 |
|
|
2020
Q3 | $2.11K | Buy |
+517,536
| New | +$1.97M | ﹤0.01% | 2557 |
|
|
2020
Q1 | – | Sell |
-16,627
| Closed | -$61K | – | 4697 |
|
|
2019
Q4 | $61K | Buy |
+16,627
| New | +$134K | ﹤0.01% | 4079 |
|
|
2019
Q2 | – | Sell |
-1,025,161
| Closed | -$9.17M | – | 4607 |
|
|
2019
Q1 | $11M | Buy |
1,025,161
+851,103
| +489% | +$9.11M | 0.02% | 1186 |
|
|
2018
Q4 | $1.52M | Buy |
174,058
+120,541
| +225% | +$1.54M | ﹤0.01% | 2368 |
|
|
2018
Q3 | $899K | Buy |
+53,517
| New | +$1.16M | ﹤0.01% | 2931 |
|
|
2018
Q2 | – | Sell |
-230,372
| Closed | -$3.71M | – | 4299 |
|
|
2018
Q1 | $3.71M | Buy |
+230,372
| New | +$4.56M | ﹤0.01% | 1981 |
|
|
2017
Q4 | – | Sell |
-222,359
| Closed | -$3.13M | – | 4172 |
|
|
2017
Q3 | $3.13M | Buy |
222,359
+140,309
| +171% | +$1.27M | ﹤0.01% | 1932 |
|
|
2017
Q2 | $611K | Buy |
82,050
+58,296
| +245% | +$381K | ﹤0.01% | 2709 |
|
|
2017
Q1 | $154K | Sell |
23,754
-359,173
| -94% | -$2.01M | ﹤0.01% | 3274 |
|
|
2016
Q4 | $1.7M | Buy |
382,927
+172,988
| +82% | +$726K | ﹤0.01% | 1971 |
|
|
2016
Q3 | $980K | Sell |
209,939
-141,860
| -40% | -$840K | ﹤0.01% | 2284 |
|
|
2016
Q2 | $2.31M | Buy |
351,799
+307,062
| +686% | +$2.17M | 0.01% | 1709 |
|
|
2016
Q1 | $285K | Sell |
44,737
-236,330
| -84% | -$1.21M | ﹤0.01% | 2794 |
|
|
2015
Q4 | $1.7M | Sell |
281,067
-402,493
| -59% | -$2.3M | ﹤0.01% | 2025 |
|
|
2015
Q3 | $4.09M | Sell |
683,560
-1,565,669
| -70% | -$10.9M | 0.01% | 1454 |
|
|
2015
Q2 | $15.4M | Buy |
2,249,229
+368,494
| +20% | +$2.34M | 0.03% | 745 |
|
|
2015
Q1 | $11.4M | Sell |
1,880,735
-2,782,520
| -60% | -$18.5M | 0.02% | 947 |
|
|
2014
Q4 | $32.3M | Sell |
4,663,255
-35,000
| -0.7% | -$257K | 0.07% | 383 |
|
|
2014
Q3 | $38.2M | Buy |
4,698,255
+4,100
| +0.1% | +$32.1K | 0.1% | 240 |
|
|
2014
Q2 | $38.2M | Sell |
4,694,155
-9,035
| -0.2% | -$68.6K | 0.11% | 215 |
|
|
2014
Q1 | $36.9M | Buy |
4,703,190
+967,332
| +26% | +$8.19M | 0.11% | 218 |
|
|
2013
Q4 | $33.1M | Buy |
3,735,858
+859,671
| +30% | +$7.68M | 0.1% | 187 |
|
|
2013
Q3 | $24.1M | Buy |
2,876,187
+848,010
| +42% | +$6.87M | 0.08% | 270 |
|
|
2013
Q2 | $15.1M | Buy |
+2,028,177
| New | +$15.6M | 0.05% | 429 |
|
Millennium Management's SPPI Position: Q3 2023 in Review
Millennium Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 389,020 shares — an estimated $373K sold.
Millennium Management first reported a position in SPPI in Q2 2013 and held it in 33 quarters. The position peaked at $38.2M in Q3 2014. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.
- Millennium Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
- Millennium Management sold 389,020 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $373K.
- Millennium Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2013 and held it in 33 quarters.
- Millennium Management's Spectrum Pharmaceuticals Inc position peaked at $38.2M in Q3 2014.
- 0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.